We show the long-term efficacy and safety of modified biliopancreatic diversion for the treatment of LPL-deficiency. How this option compares with gene therapy is difficult to evaluate due to limited experience. Surgery may be the first option in patients in whom medical therapy is ineffective and gene therapy not applicable.
A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion / Nosso, Gabriella; Capaldo, Brunella; Cocozza, Sara; Vaccaro, Olga. - In: CLINICAL CASE REPORTS. - ISSN 2050-0904. - 3:12(2015), pp. 1030-3-1033. [10.1002/ccr3.433]
A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion
NOSSO, GABRIELLA;CAPALDO, BRUNELLA;COCOZZA, SARA;VACCARO, OLGA
2015
Abstract
We show the long-term efficacy and safety of modified biliopancreatic diversion for the treatment of LPL-deficiency. How this option compares with gene therapy is difficult to evaluate due to limited experience. Surgery may be the first option in patients in whom medical therapy is ineffective and gene therapy not applicable.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
